ARC-AGI-3 benchmark gains its first fully open-source agent: NIMI's Tycho writes Python code as falsifiable hypotheses about ...

This Python tutorial explains how functions work and why they are essential for writing reusable, organized code. The lesson begins with creating a basic function using the def keyword, calling it, ...

You can now write generative AI processes in BigQuery using "standard SQL." Two functions, AI.GENERATE and AI.GENERATE_TABLE, are now GA (Generally Available), allowing you to process multiple data ...

*Note: For consistency, wattage ranges and starting prices listed above apply only to standby generators. Other generator types, such as portable and inverter generators, may have different power ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

With U.S. electricity demand starting to rise quickly and expected to continue rising, largely because of the power needed for data centers that process artificial intelligence, people are looking for ...

Hundreds of thousands of generators sold at retailers such as Costco, Lowe’s and Home Depot are being recalled due to serious safety hazards. According to warnings from the U.S. Consumer Product ...

Nearly 150,000 generators sold at stores like Home Depot and Lowe’s are being recalled for posing a deadly fire hazard. According to an April 16 warning from the U.S. Consumer Product Safety ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...